The Global Pharmaceuticals sector witnessed 71 Private Equity/Venture Financing deals in July 2022, for an aggregate deal value of $1,845.7 million. This represents a decrease of 78.8% in terms of value and a decrease of 43.0% in terms of volume, year over year.
A total of 1304 Private Equity/Venture Financing deals were recorded over the last twelve months (LTM) for an aggregate deal value of $49,138.0 million. In the LTM period, August 2021, turned out to be the most prolific in terms of deal size, with a total deal value of $1.4 million and a deal volume of 2 during that month. On the other hand, the month of December 2021, was the most prolific in terms of deal volume, recording a total of 140 deals with a total deal value of $4,119.3 million during that month.
On an average, over the LTM period, 108 deals were done with an average deal size of $4,094.8 million.
United States of America
China
Switzerland
United States of America
United States of America
United States of America
United States of America
Germany
France
Switzerland
Don’t wait - discover a universe of connected data & insights with your next search. Browse over 28M data points across 22 industries.
Access more premium companies when you subscribe to Explorer